The Trump administration’s decision to launch a Section 301 investigation into Germany’s pharmaceutical pricing system has triggered a sharp rebuke from the European Parliament’s Trade Committee Chair Bernd Lange (S&D, Germany).
“Unfortunately, this is no bad joke: the US…
Leave a Reply